TSE Filings

Notice regarding Specific Action Plan and Update of Performance Targets related to Management Policy "Forging the future"

Notice on Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2023

Notice of Award for the Arbitration Filed against Mitsubishi Tanabe Pharma Corporation, a Consolidated Subsidiary

Notice on Absorption-type Merger of a Wholly-owned Subsidiary (Simplified Merger and Short-form Merger)

Earnings Impact due to Cessation of MMA-related Product Production at Mitsubishi Chemical UK Limited and Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2023

Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2023

Notice Regarding Changes in Representative Corporate Executive Officer

Notice on Cessation of the Production of Methacrylates in Mitsubishi Chemical UK Limited

Notice on the Start of Consultation on Cessation of the Production of Methacrylates in Mitsubishi Chemical UK Limited

Notice On Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2023

Consolidated Financial Results for the First Half of the Fiscal Year Ending March 31, 2023 (Under IFRS)

Corporate Split in Tandem with Intergroup Organizational Restructuring

Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2023 (Under IFRS)

Regarding Some News Reports Today

Notice on Change of Trade Name and Partial Amendment to Articles of Incorporation

Announcement Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2024

Notice Regarding Distribution of Dividends from Surplus

Consolidated Financial Results for the Fiscal Year Ended March 31, 2022 (Under IFRS)

Notice Regarding Disposition of Treasury Shares as Equity Compensation in the Form of Restricted Shares

Notice on Absorption-type Merger of a Wholly-owned Subsidiary (Simplified Merger and Short-form Merger)

Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2022 (Under IFRS)

Notice Regarding Changes in Representative Corporate Executive Officers

Notice of Changes Regarding the Corporate Executive Officer and Chief Financial Officer

Notice of Revision to Consolidated Financial Results Forecast, Distribution of Dividend (Interim Dividend) of Surplus, and Revision to Year-end Dividend Forecast for the Fiscal Year Ending March 31, 2022

Consolidated Financial Results for the First Half of the Fiscal Year Ending March 31, 2022 (Under IFRS)

Notice on Company Split (Simplified Absorption-type Company Split) and Share Transfer in Line with Transfer of the Polycrystalline Alumina Fiber Business of the Consolidated Subsidiary (Mitsubishi Chemical Corporation)

Notice Regarding Revision to Consolidated Financial Results Forecast for the First Half of Fiscal Year Ending March 31, 2022

Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2022 (Under IFRS)

Notice on Continuation of Performance-based Share Compensation Program Which Uses a Trust

Announcement Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2022 and Zero Coupon Convertible Bonds due 2024

Notice Regarding Distribution of Dividends from Surplus

Consolidated Financial Results for the Fiscal Year Ended March 31, 2021 (Under IFRS)

Notice Regarding Differences between Financial Results Forecast and Financial Results for the Fiscal Year Ended March 31, 2021

Notice Regarding Disposition of Treasury Shares as Equity Compensation in the Form of Restricted Shares and Introduction of Performance-Linked Equity Compensation (Performance Share Unit) Scheme

Formulation of New Medium-Term Management Plan APTSIS 25 Step 1

Notice Regarding Changes in Representative Corporate Executive Officers

Condensed Consolidated Financial Information for the Third Quarter of the Fiscal Year Ending March 31, 2021

Notice Regarding Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2021

Condensed Consolidated Financial Information for the First Half of the Fiscal Year Ending March 31, 2021

Mitsubishi Chemical to End MMA Monomer and MAA Production in Texas and Close Site

Notice Regarding Differences between Financial Results Forecast and
Financial Results for the First Half of Fiscal 2020, and Revisions to Annual Forecast

Notice Regarding the Recording of Impairment Loss

Notice Regarding Change in Representative Corporate Executive Officers

Condensed Consolidated Financial Information for the First Quarter of the Fiscal Year Ending March 31, 2021

Announcement Regarding Adjustment of Conversion Price for
Zero Coupon Convertible Bonds due 2022 and
Zero Coupon Convertible Bonds due 2024

Notice Regarding Disposition of Treasury Shares as Equity Compensation in the
Form of Restricted Shares

Notice Regarding Distribution of Dividends from Surplus

Taiyo Nippon Sanso Corporation Announces
Notice of Absorption-Type Company Split Agreement for Transition to a Holding Company Structure Through Company Split and Partial Amendments to Articles of Incorporation (Tradename and Business Purpose)

Condensed Consolidated Financial Information for the Fiscal Year Ended March 31, 2020

Notice of Revision to Consolidated Financial Results Forecast and Dividends Forecast for the Fiscal Year Ended March 31, 2020

Notice on Revision to Consolidated Financial Results Forecast
for the Fiscal Year Ending March 31, 2020

Consolidated Financial Information for the Third Quarter of the Fiscal Year Ending March 31, 2020

Taiyo Nippon Sanso Corporation Announces “Notice of Transition to a Holding Company Structure Through Company Split, Incorporation of a Subsidiary (Company-Split Preparation Company), and Partial Amendment to the Articles of Incorporation (Tradename Change)”

Announcement in Relation to Results of Tender Offer for Shares of Mitsubishi Tanabe Pharma Corporation (Securities Code: 4508)

Announcement of Commencement of Tender Offer for Shares of Mitsubishi Tanabe Pharma Corporation (Securities Code: 4508)

Consolidated Financial Information for the First Half of the Fiscal Year Ending March 31, 2020

Notice on Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2020

Consolidated Financial Information for the First Quarter of the Fiscal Year Ending March 31, 2020

Notice Regarding Distribution of Dividends from Surplus

Announcement Regarding Adjustment of Conversion Price for
Zero Coupon Convertible Bonds due 2022 and
Zero Coupon Convertible Bonds due 2024

Condensed Consolidated Financial Information for the Fiscal Year Ended March 31, 2019

Taiyo Nippon Sanso Corporation Announces
“Notice Regarding Financing through a Subordinated Loan”

Notice Regarding Completed Acquisition of a HyCO Business and Related Assets
in the United States

Notice Regarding Changes in Representative Corporate Executive Officers

Mitsubishi Tanabe Pharma Corporation Received Notice of Request for Arbitration

Consolidated Financial Information for the Third Quarter of the Fiscal Year Ending March 31, 2019

Taiyo Nippon Sanso Corporation Announces
“Notice Regarding Determination of Issuance Conditions for Hybrid Bonds
(Public Subordinated Bonds)”

Taiyo Nippon Sanso Corporation Announces “Notice Regarding Acquisition of
a HyCO Business and Related Assets in the United States”

Revision of Targets under Medium-Term Management Plan APTSIS20

Taiyo Nippon Sanso Corporation Announces “Notice Regarding Issue of Hybrid Bonds (Public Subordinated Bonds)”

Taiyo Nippon Sanso Corporation Announces“Notice Regarding Completed Acquisition (100% Ownership) Procedures of US Company Praxair, Inc.’s European Businesses”

Taiyo Nippon Sanso Corporation Announces Notice of Conclusion of Bridge Loan Agreement Concerning Acquisition (100% Ownership) of US Company, Praxair, Inc.’s European Businesses

Notice Regarding Changes in Specified Subsidiaries

Revision of Forecasts for Consolidated Financial Results and Dividends for Fiscal Year Ending March 31, 2019

Notice Regarding Distribution of Dividends from Surplus (Interim Dividend)

Consolidated Financial Information for the First Half of the Fiscal Year Ending March 31, 2019

Notice Regarding Differences between Consolidated Financial Results Forecast and Financial Results for the First Half of the Fiscal Year Ending March 31, 2019

Notice Regarding Disposition of Treasury Shares through Third-party Allotment Associated with Introduction of New Performance-based Share Compensation Plan

Consolidated Financial Information for the First Quarter of the Fiscal Year Ending March 31, 2019

Announcement Regarding the Setting of Terms for Issuance of Stock Acquisition Rights(Stock Options as Stock-Linked Compensation) to Corporate Executive Officers

(Updated)Partial Revision to the “Notice of Acquisition (100% Ownership) of US Company,Praxair, Inc.’s European Businesses”

Announcement Regarding the Issuance of Stock Acquisition Rights(Stock Options as Stock-Linked Compensation) to Executive Officers, etc.

Announcement Regarding the Issuance of Stock Acquisition Rights(Stock Options as Stock-Linked Compensation) to Corporate Executive Officers

Notice of Acquisition (100% Ownership) of US Company, Praxair, Inc.’s European Businesses

Announcement Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2022 and Zero Coupon Convertible Bonds due 2024

Notice on Introduction of New Performance-based Share Compensation Plan

Notice Regarding Result and Completion of Acquisition of Treasury Stock

Notice Regarding Distribution of Dividends from Surplus

Notice Regarding Result of Acquisition of Treasury Stock through Off-Auction Own Shares Repurchase Trading System (ToSTNeT-3)

Notice Regarding Revision to Dividend Forecast for the Fiscal Year Ended March 31, 2018

Notice Regarding Acquisition of Treasury Stock and Share Buyback through Off-Auction Own Shares Repurchase Trading System (ToSTNeT-3)

Condensed Consolidated Financial Information for the Fiscal Year Ended March 31, 2018

Announcement on Determination of Acquisition Price through Off-Auction Own Shares Repurchase Trading System (ToSTNeT-3)

Mitsubishi Chemical Announces MMA Monomer and PMMA Plants Start Commercial Operations in Saudi Arabia

Notice Regarding Changes in Representative Corporate Executive Officers and Corporate Executive Officer

Revision to Consolidated Financial Results Forecast for Fiscal Year Ending March 31, 2018

Financial Results Announcement for the Third Quarter of the Fiscal Year Ending March 31, 2018

Notice Regarding Change in Representative Directors at Consolidated Subsidiary (Mitsubishi Chemical Corporation)

Consolidated Financial Information for the First Half of the Fiscal Year Ending March 31, 2018

Notice Concerning Sale of Shares Held by Untraceable Shareholders

Revision of Forecasts for Consolidated Financial Results and Dividends for Fiscal Year Ending March 31, 2018

Results Announcement for the First Quarter of the Fiscal Year Ending March 31, 2018

Announcement Regarding the Setting of Terms for Issuance of Stock Acquisition Rights
(Stock Options as Stock-Linked Compensation) to corporate executive officers

Mitsubishi Tanabe Pharma to Acquire NeuroDerm Ltd.

Announcement Regarding the Issuance of Stock Acquisition Rights (Stock Options as Stock-Linked Compensation) to Corporate Executive Officers

Announcement Regarding the Issuance of Stock Acquisition Rights (Stock Options as Stock-Linked Compensation) to Executive Officers, etc.

Announcement of Additional Disclosure of “Condensed Consolidated Financial Information for the Fiscal Year Ended March 31, 2017 Announced on May 12, 2017

Notice Regarding Distribution of Dividends from Surplus

Notice Regarding Revision to Dividend Forecast for the Fiscal Year Ended March 31, 2017

Announcement Regarding Result and Completion of Repurchase of Treasury Stock
through Off-Auction Treasury Stock Repurchase Trading System (ToSTNeT-3)

Announcement Regarding the Issuance of Zero Coupon Convertible Bonds due 2022
and Zero Coupon Convertible Bonds due 2024

Announcement Regarding Repurchase of Treasury Stock

Financial Results Announcement for the Third Quarter of the Fiscal Year Ending March 31, 2017

Revision of Forecasts for Consolidated Financial Results and Dividends
for Fiscal Year Ending March 31, 2017

Notice Regarding a Corporate Split-Off

Announcement Regarding Disposition of Treasury Shares
via Allotment to Subsidiary

Financial Results Announcement for the First Half of the Fiscal Year Ending March 31, 2017

Revision to First Half and Full Year Consolidated Financial Results Forecasts
for Fiscal Year Ending March 31, 2017

Announcement regarding the Conversion of Nippon Kasei Chemical
by means of the Share Exchange into a Wholly-Owned Subsidiary of
Mitsubishi Chemical Corporation

Notice Regarding Change in Trade Name of Consolidated Subsidiary

Financial Results Announcement for the First Quarter of the Fiscal Year Ending March 31, 2017

Announcement of Commencement of Tender Offer for Shares of
The Nippon Synthetic Chemical Industry Co., Ltd. by Our Consolidated Subsidiaries

Notice Regarding Reorganization of Purified Terephtharic Acid Business
in India and China

Announcement Regarding the Setting of Terms for Issuance of Stock Acquisition Rights
(Stock Options as Stock-Linked Compensation) to Directors

Announcement Regarding the Issuance of Stock Acquisition Rights (Stock Options as Stock-Linked Compensation) to Executive Officers, etc.

Announcement Regarding the Issuance of Stock Acquisition Rights (Stock Options as Stock-Linked Compensation) to Corporate Executive Officers

Notice Regarding Top Executives and Management Structure of New Integrated Company

Notice Regarding Distribution of Dividends from Surplus

Notice Regarding Revision to Dividend Forecast for the Fiscal Year Ended March 31, 2016

Financial Results Announcement for the Fiscal Year Ended March 31, 2016

Top Executives Named for Newly Formed
Asahi Kasei Mitsubishi Chemical Ethylene Corporation

Notice Regarding Trade Name of New Integrated Company

Notice Regarding a Corporate Split-Off (Simplified/Abbreviated Split-Off)

Financial Results Announcement for the Third Quarter of the Fiscal Year Ending March 31, 2016

Recognition of Impairment Loss and Revision to Consolidated Financial Results Forecasts
for the Fiscal Year Ending March 31, 2016

Formulation of APTSIS 20 New Medium-Term Management Plan

Notice Regarding Integration of Three Consolidated Subsidiaries

Financial Results Announcement for the First Half of the Fiscal Year Ending March 31, 2016

Revision to Consolidated Financial Results Forecasts for the Fiscal Year Ending March 31, 2016

Announcement Regarding the Setting of Terms for Issuance of Stock Acquisition Rights (Stock Options as Stock-Linked Compensation) to Directors

Announcement Regarding the Issuance of Stock Acquisition Rights
(Stock Options as Stock-Linked Compensation) to Executive Officers, etc.

Announcement Regarding the Issuance of Stock Acquisition Rights
(Stock Options as Stock-Linked Compensation) to Directors

Amendment to "Announcement Regarding the Issuance of Stock Acquisition Rights (Stock Options as Stock-Linked Compensation) to Directors"

Financial Results Announcement for the First Quarter of the Fiscal Year Ending March 31, 2016

Revision to Consolidated Financial Results Forecasts for the First Half of Fiscal Year Ending March 31, 2016

Mitsubishi Chemical Holdings Group Begins Study of Organizational Restructuring
with an Eye toward Integration of Chemical Operating Companies

Establishment of a Joint Venture for Operation of Unified Naphtha Cracker in Mizushima

Partial Amendment to the Articles of Incorporation

Financial Results Announcement for the Fiscal Year Ended March 31, 2015

Revision of Forecasts for Consolidated Financial Results and Dividends for the Fiscal Year Ending March 31, 2015

Announcement Regarding Changes in Representative Corporate Executive Officers

Notice Regarding Change in Representative Directors

(Corrections) Notice on Acquisition of Treasury Stock from a Subsidiary -Acquisition of Treasury Stock Pursuant to Article 163 of the Companies Act-

Notice on Acquisition of Treasury Stock from a Subsidiary

Financial Results Announcement for the Third Quarter of the Fiscal Year Ending March 31, 2015

Announcement Regarding Executive Personnel Changes and Transfer to a Company with Committees

Revision to Consolidated Financial Results Forecasts for the Fiscal Year Ending March 31, 2015

Announcement of Results of Tender Offer for Shares of Taiyo Nippon Sanso Corporation (TSE Code: 4091) and Change in Subsidiary

Financial Results Announcement for the First Half of the Fiscal Year Ending March 31, 2015

Revision to the Consolidated Financial Results Forecasts for the First Half of Fiscal Year Ending March 31, 2015

Mitsubishi Tanabe Pharma Announces a Revision to the Consolidated Financial Forecasts for Fiscal Year Ending March 31, 2015

Announcement of Commencement of Tender Offer for Shares of Taiyo Nippon Sanso Corporation (TSE Code: 4091)

Financial Results Announcement for the First Quarter of the Fiscal Year Ending March 31, 2015

Mitsubishi Rayon Announces Establishment of MMA Monomer/PMMA Joint Venture in Saudi Arabia, and Order for Plant Construction

Notice Regarding Voluntary Adoption of International Financial Reporting Standards (IFRS)

Notice Regarding Execution of an Agreement in connection with Tender Offer by Mitsubishi Chemical Holdings Corporation for Shares of Taiyo Nippon Sanso Corporation

Financial Results Announcement for the Fiscal Year Ended March 31, 2014

Changes in Representative Directors

Mitsubishi Chemical Holdings to Establish Life Science Institute, Inc.

Revision to Consolidated Financial Results Forecasts for Fiscal Year Ending March 31, 2014

Financial Results Announcement for the Third Quarter of the Fiscal Year Ending March 31, 2014

Revision to Consolidated Financial Results Forecasts for Fiscal Year Ending March 31, 2014

Financial Results Announcement for the First Half of the Fiscal Year Ending March 31, 2014

Revision to the Consolidated Financial Results Forecasts for the Fist Half of Fiscal Year Ending March 31, 2014

Mitsubishi Tanabe Pharma Announces Notice Regarding Administrative Action Related to Violation of Pharmaceutical Affairs Law of Japan

Notice of change in the number of shares constituting one unit and amendment to the Articles of Incorporation

Notice regarding the Capital and Business Alliance between Mitsubishi Chemical Group Corporation and Taiyo Nippon Sanso Corporation

Mitsubishi Tanabe Pharma Announces a Revision to 2Q Consolidated Financial Forecasts for Fiscal Year Ending March 31, 2014

Notice Regarding Completion of Acquisition of Shares of Medicago, lnc., a Pharmaceutical Company Based in Canada, Which Has Become a Subsidiary of Mitsubishi Tanabe Pharma

Progress in study for unification of naphtha cracker facilities in Mizushima

Financial Results Announcement for the First Quarter of the Fiscal Year Ending March 31, 2014

Notice Regarding the Acquisition of Medicago Inc.

Financial Results Announcement for the Fiscal Year Ended March 31, 2013

Announcement Regarding the Medium-term Management Plan, APTSIS 15

Completion of Acquisition of the Qualicaps Co., Ltd.

Revision to Consolidated Financial Results Forecasts for the Fiscal Year Ending March 31, 2013

Financial Results Announcement for the Third Quarter of the Fiscal Year Ending March 31, 2013